SECUKINUMAB

98074 reported adverse events

Drug classes: Interleukin-17A Antagonist [EPC]

These side effects are most commonly reported by patients taking SECUKINUMAB:

# Side effect Count
0 DRUG INEFFECTIVE 16734
1 PSORIASIS 14209
2 PAIN 7811
3 ARTHRALGIA 6946
4 MALAISE 4989
5 PRURITUS 4562
6 FATIGUE 4224
7 PSORIATIC ARTHROPATHY 3825
8 DIARRHOEA 3753
9 RASH 3557
See all common reactions for SECUKINUMAB

SECUKINUMAB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PSORIASIS AREA SEVERITY INDEX INCREASED 27 0.4286
1 TONSILLAR ULCER 41 0.3475
2 REBOUND PSORIASIS 68 0.3022
3 MACULE 547 0.2911
4 RED BLOOD CELL SEDIMENTATION RATE 45 0.2711
5 DACTYLITIS 139 0.2628
6 NAIL PSORIASIS 82 0.2571
7 ENTHESOPATHY 233 0.2524
8 SERONEGATIVE ARTHRITIS 117 0.2505
9 SKIN PLAQUE 1111 0.2113
See all enriched reactions for SECUKINUMAB